Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2019

01-11-2019 | Infliximab | Multicenter Seminars: IBD (MUSE: IBD)

It’s What’s Up Front That Counts—Part One: Endoscopic Diagnosis and Therapy of Esophageal Crohn’s Disease

Authors: Latifat Alli-Akintade, Jennifer Hewitt, Asraa Namiq, Maneesh Singh, Yume Nguyen, Sara Keihanian, Jennifer T. Chang, Sundip Karsan, Samuel Tesfay, Fernando S. Velayos

Published in: Digestive Diseases and Sciences | Issue 11/2019

Login to get access

Excerpt

A 31-year-old woman initially diagnosed with Crohn’s colitis at age 2 while being assessed for blood diarrhea was evaluated for recurrent dysphagia. …
Literature
1.
go back to reference Laube R, Liu K, Schifter M, Yang JL, Suen MK, Leong RW. Oral and upper gastrointestinal Crohn’s disease. J Gastroenterol Hepatol. 2018;33:355–364.CrossRefPubMed Laube R, Liu K, Schifter M, Yang JL, Suen MK, Leong RW. Oral and upper gastrointestinal Crohn’s disease. J Gastroenterol Hepatol. 2018;33:355–364.CrossRefPubMed
2.
go back to reference Crowley E, Muise A. Inflammatory bowel disease: What very early onset disease teaches us. Gastroenterol Clin N Am. 2018;47:755–772.CrossRef Crowley E, Muise A. Inflammatory bowel disease: What very early onset disease teaches us. Gastroenterol Clin N Am. 2018;47:755–772.CrossRef
3.
go back to reference De Felice KM, Katzka DA, Raffals LE. Crohn’s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21:2106–2113.CrossRefPubMed De Felice KM, Katzka DA, Raffals LE. Crohn’s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21:2106–2113.CrossRefPubMed
5.
go back to reference Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn’s disease patients. Pathol Res Pract. 1985;179:377–387.CrossRefPubMed Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn’s disease patients. Pathol Res Pract. 1985;179:377–387.CrossRefPubMed
6.
go back to reference Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn’s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol. 2012;10:208.CrossRefPubMedPubMedCentral Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn’s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol. 2012;10:208.CrossRefPubMedPubMedCentral
7.
go back to reference Bonavina L, Bettineschi F, Cecchetto A, Pomerri F. Crohn’s disease of the esophagus. Dysphagia. 1989;4:176–179.CrossRefPubMed Bonavina L, Bettineschi F, Cecchetto A, Pomerri F. Crohn’s disease of the esophagus. Dysphagia. 1989;4:176–179.CrossRefPubMed
8.
go back to reference Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2017;11:3–25.CrossRef Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2017;11:3–25.CrossRef
9.
go back to reference Grassia R, Staiano T, Buffoli F, Paolo B. Severe esophageal Crohn’s disease: healing of lesions after 1 week therapy with infliximab. J Crohn’s Colitis. 2009;3:138–139.CrossRef Grassia R, Staiano T, Buffoli F, Paolo B. Severe esophageal Crohn’s disease: healing of lesions after 1 week therapy with infliximab. J Crohn’s Colitis. 2009;3:138–139.CrossRef
10.
go back to reference Kwan LY, Conklin JL, Papadakis KA. Esophageal Crohn’s disease treated successfully with adalimumab. Inflamm Bowel Dis. 2007;13:639–640.CrossRefPubMed Kwan LY, Conklin JL, Papadakis KA. Esophageal Crohn’s disease treated successfully with adalimumab. Inflamm Bowel Dis. 2007;13:639–640.CrossRefPubMed
12.
go back to reference Nathoo S, Hood WA, Keihanian S, Collinsworth AL, Glover SC. Tofacitinib for the treatment of tumor necrosis factor-alpha inhibitor refractory esophageal Crohn’s disease: a case report. J Med Case Rep. 2016;10:264.CrossRefPubMedPubMedCentral Nathoo S, Hood WA, Keihanian S, Collinsworth AL, Glover SC. Tofacitinib for the treatment of tumor necrosis factor-alpha inhibitor refractory esophageal Crohn’s disease: a case report. J Med Case Rep. 2016;10:264.CrossRefPubMedPubMedCentral
Metadata
Title
It’s What’s Up Front That Counts—Part One: Endoscopic Diagnosis and Therapy of Esophageal Crohn’s Disease
Authors
Latifat Alli-Akintade
Jennifer Hewitt
Asraa Namiq
Maneesh Singh
Yume Nguyen
Sara Keihanian
Jennifer T. Chang
Sundip Karsan
Samuel Tesfay
Fernando S. Velayos
Publication date
01-11-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05833-x

Other articles of this Issue 11/2019

Digestive Diseases and Sciences 11/2019 Go to the issue